After Heart Failure Hospitalization, VERQUVO® (vericiguat) May Help You Live Longer and Stay Out of the Hospital

Helpful resources to support you along the way

VERQUVO® (vericiguat): Patient Brochure

Patient Brochure

Would you like to have information about VERQUVO right at your fingertips? This downloadable brochure includes helpful information, such as what VERQUVO is, how it works, potential side effects, tips for living with heart failure, and more.

Doctor Discussion Guide - A Handy Guide for Talking With Your Doctor About VERQUVO®(vericiguat)

Doctor Discussion Guide

Looking for a conversation starter to help you talk to your doctor about treatment? This handy guide includes some questions to bring to your next appointment, so you and your doctor can determine if VERQUVO is right for you.

VERQUVO® (vericiguat): Caregiver Brochure

Caregiver Brochure

Have questions about how to best manage your loved one's care? This brochure, complete with a Symptom Tracker, offers helpful tips to support your loved one on their treatment journey.

Check back later for additional resources.

What is VERQUVO?

VERQUVO is a prescription medicine used in adults who are having symptoms of their chronic (long-lasting) heart failure, who have had a recent hospitalization or the need to receive intravenous (IV) medicines and have an ejection fraction (amount of blood pumped with each heartbeat) of less than 45 percent to reduce the risk of dying and to reduce the need to be hospitalized.


VERQUVO may cause birth defects if taken during pregnancy.

  • Females must not be pregnant when they start taking VERQUVO.
  • For females who are able to get pregnant:
  • Your healthcare provider will do a pregnancy test to make sure that you are not pregnant before you start taking VERQUVO.
  • You must use effective forms of birth control during treatment and for 1 month after you stop treatment with VERQUVO. Talk to your healthcare provider about forms of birth control that you may use to prevent pregnancy during treatment.
  • Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment with VERQUVO.
  • There is a Pregnancy Surveillance Program that monitors pregnancy outcomes in women exposed to VERQUVO during pregnancy. Patients should report any exposure to VERQUVO during pregnancy by calling  1-877-888-4231or at

Do not take VERQUVO if you:

  • are taking another medicine called a soluble guanylate cyclase stimulator (sGC). Ask your healthcare provider if you are not sure if you are taking an sGC medicine.
  • are pregnant.

Before taking VERQUVO, tell your healthcare provider about all your medical conditions, including if you:

  • are breastfeeding or plan to breastfeed. It is not known if VERQUVO passes into your breast milk. Do not breastfeed if you take VERQUVO. Talk with your healthcare provider about the best way to feed your baby if you take VERQUVO.

Tell your healthcare provider about all the medicines you take. Certain other medicines may affect how VERQUVO works.

The most common side effects of VERQUVO include:

  • low blood pressure
  • low red blood cells (anemia)

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit or call 1-800-FDA-1088.

Please read the accompanying Medication Guide for VERQUVO, including the information about birth defects if taken during pregnancy, and discuss it with your doctor. The physician Prescribing Information also is available.